002476.SHE Shandong Polymer Biochemicals Co Ltd
- Market cap
- CNY 2.59B
- P/E
- 424.0x
- P/B
- 2.69x
- ROE
- 1.7%
- Dividend yield
- 0.29%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 002476.SHE undervalued?
Graham numberThe Graham number of Shandong Polymer Biochemicals Co Ltd cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Shandong Polymer Biochemicals Co Ltd fundamental analysis
No fundamental analysis for Shandong Polymer Biochemicals Co Ltd yet.
Shandong Polymer Biochemicals Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Shandong Polymer Biochemicals Co Ltd
Shandong Newleaf Chemical Co., Ltd., together with its subsidiaries, engages in the production and sale of special chemicals for oil and gas exploitation in China and internationally. The company produces acrylamide, polyacrylamide, surfactant, demulsification and water purification agent, fracturing fluid, and other products. It also offers comprehensive technical services for oil field stimulation and oil recovery, and environmental protection water treatment products and …
Full company profileShandong Polymer Biochemicals Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Shandong Polymer Biochemicals Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 898M | 410M | 450M | 417M | 447M | 657M | 592M | 387M | 539M | 603M | 662M |
| Gross Profit | 172M | 55.2M | 50.3M | 51.8M | 83.4M | 100M | 129M | 65.1M | 97.2M | 106M | 99.6M |
| Operating Income | -1.12M | -1.34M | -152M | -24.4M | 17.3M | 18.2M | 30.7M | 10.8M | 55.9M | 26.6M | 17.5M |
| EBITDA | 90.0M | 53.4M | -218M | 142M | 67.4M | 56.0M | 64.7M | 34.1M | 82.9M | 57.1M | 17.2M |
| Net Income | 14.8M | 8.27M | -264M | 91.2M | 13.2M | 17.9M | 29.7M | 5.23M | 56.4M | 31.3M | 16.6M |
| EPS | 0.02 | 0.01 | -0.43 | 0.15 | 0.02 | 0.03 | 0.05 | 0.01 | 0.09 | 0.05 | 0.03 |
| Balance Sheet | |||||||||||
| Total Assets | 1.45B | 1.28B | 1.05B | 965M | 1.01B | 992M | 1.04B | 964M | 1.05B | 1.14B | 1.09B |
| Total Liabilities | 414M | 287M | 335M | 156M | 188M | 152M | 170M | 87.1M | 124M | 186M | 129M |
| Shareholders' Equity | 988M | 988M | 718M | 809M | 822M | 840M | 870M | 877M | 927M | 950M | 965M |
| Cash & Short-term Investments | 133M | 455M | 442M | 415M | 362M | 401M | 306M | 267M | 437M | 495M | 174M |
| Total Debt | 97.2M | 97.5M | 68.0M | 66.1M | 121M | 1.60M | 11.4M | 21.9M | 39.4M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 145M | 87.9M | 52.7M | 50.6M | 32.5M | -34.8M | -78.2M | 121M | 30.5M | 26.5M | - |
| Capital Expenditure | 117M | 86.7M | 31.6M | 10.4M | 17.7M | 19.2M | 15.0M | 6.97M | 5.95M | 21.8M | 15.0M |
| Free Cash Flow | 28.2M | 1.24M | 21.1M | 40.2M | 14.9M | -54.0M | -93.2M | 114M | 24.6M | 4.71M | -165M |
| Ratios | |||||||||||
| ROE | 1.5% | 0.8% | -36.8% | 11.3% | 1.6% | 2.1% | 3.4% | 0.6% | 6.1% | 3.3% | 1.7% |
| ROA | 1.0% | 0.6% | -25.1% | 9.5% | 1.3% | 1.8% | 2.9% | 0.5% | 5.4% | 2.8% | 1.5% |
| Net Profit Margin | 1.7% | 2.0% | -58.7% | 21.9% | 2.9% | 2.7% | 5.0% | 1.4% | 10.5% | 5.2% | 2.5% |
| Debt to Equity | 0.10x | 0.10x | 0.09x | 0.08x | 0.15x | 0.00x | 0.01x | 0.02x | 0.04x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Shandong Polymer Biochemicals Co Ltd dividends
- Dividend yield
- 0.29%
- Forward dividend
- -
- Payout ratio
- 24.1%
- Ex-dividend date
- Jun 18, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 7.55M | 0.01 | 24.1% |
| 2024 | CNY 7.03M | 0.01 | 12.5% |
| 2023 | CNY 618K | 0.00 | 11.8% |
| 2022 | CNY 413K | 0.00 | 1.4% |
| 2021 | CNY 5.67M | 0.01 | 31.6% |
| 2020 | CNY 10.4M | 0.02 | 78.6% |
| 2019 | CNY 4.56M | 0.01 | 5.0% |
| 2018 | CNY 11.2M | 0.02 | - |
| 2017 | CNY 19.8M | 0.03 | 238.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.5:1 on May 27, 2013.
Who owns Shandong Polymer Biochemicals Co Ltd
- Insiders 25.71%
- Institutions 0.31%
- Public & others 73.98%
- Shares outstanding 612M
- Free float 479M
Shandong Polymer Biochemicals Co Ltd company profile
- Company name
- Shandong Polymer Biochemicals Co Ltd
- Ticker
- 002476.SHE
- ISIN
- CNE100000TN8
- Exchange
- Shenzhen Stock Exchange
- Listed since
- Sep 15, 2010
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 435
- Fiscal year end
- December
- Address
- No. 892, Xisi Road, Dongying, China, 257081
- Phone
- 86 54 6777 5226
- Website
- slcapam.com
About Shandong Polymer Biochemicals Co Ltd
Shandong Newleaf Chemical Co., Ltd., together with its subsidiaries, engages in the production and sale of special chemicals for oil and gas exploitation in China and internationally. The company produces acrylamide, polyacrylamide, surfactant, demulsification and water purification agent, fracturing fluid, and other products. It also offers comprehensive technical services for oil field stimulation and oil recovery, and environmental protection water treatment products and technical services. The company was formerly known as Shandong Polymer Biochemicals Co., Ltd. and changed its name to Shandong Newleaf Chemical Co., Ltd. in June 2026. Shandong Newleaf Chemical Co., Ltd. was founded in 1996 and is headquartered in Dongying, China.
Shandong Polymer Biochemicals Co Ltd management
4- Mr. Ding LiGM, Board Secretary & Non-Independent Director · born 1985
- Mr. Shipeng ZhangDeputy General Manager · born 1979
- Ms. Shuyi WangChief Financial Officer · born 1981
- Yan RenAccounting Supervisor